DMK Pharmaceuticals: Q3 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — DMK Pharmaceuticals Corporation (DMK) on Tuesday reported a loss of $1.4 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 20 cents. Losses, adjusted to account for discontinued operations, came to 25 cents per share.

The biopharmaceutical company posted revenue of $9,100 in the period. Its adjusted revenue was $9,000.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DMK at https://www.zacks.com/ap/DMK